|
1
|
Apostolidou S, Hadwin R, Burnell M, Jones
A, Baff D, Pyndiah N, Mould T, Jacobs IJ, Beddows S, Kocjan G and
Widschwendter M: DNA methylation analysis in liquid-based cytology
for cervical cancer screening. Int J Cancer. 125:2995–3002. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jiang BG, Chen AE and Li ZT: Clinical and
pathological characteristics of early cervical carcinoma in women
under 35 years of age. Mod Pract Med. 3:141–142. 2002.
|
|
3
|
Liu WX: Clinieal and prognostic analysis
of iuvasvie cevrical careinoma in women aged 40 and yunger
(unpublished PhD thesis). Tianjin Medical University. 2002.
|
|
4
|
Yu HY and Zhang X: Clinical
characteristics and prognosis of young women with cervical cancer.
China Health Care Nutrition. 08:793–794. 2012.
|
|
5
|
Bray F, Carstensen B, Moller H, Møller H,
Zappa M, Zakelj MP, Lawrence G, Hakama M and Weiderpass E:
Incidence trends of adenocarcinoma of the cervix in 13 European
countrines. Cancer Epidemiol Biomarkers Prev. 14:2181–2199. 2005.
View Article : Google Scholar
|
|
6
|
Wang SS, Sherman ME, Hildesheim A, Lacey
JV Jr and Devesa S: Cervical adenocarcinomal and squamous cell
carcinoma incidence trends among white women and black women in the
United States for 1976–2000. Cancer. 100:1035–1044. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Castellsagué X, Díaz M, de Sanjosè S,
Muñoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS,
Snijders PJ, et al: Worldwide human papillomavirus etiology of
cervical adenocanimoma and its cofactors: Impications for screening
and prevention. J Natl Cancer Inst. 98:303–315. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sasieni P, Castanon A and Cuzick J:
Screening and adenocarcinoma of the cervix. Int J Cancer.
125:525–529. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun JH, Cai SM and Gao YL: Some problems
in gynecologic oncology and training of Gynecologic Oncology.
Zhonghua Zhong Liu Za Zhi. 31:946–948. 2009.(In Chinese).
PubMed/NCBI
|
|
10
|
Boabang P, Kurbacher CM, Waida A and
Amo-Takyi BK: Detection of aberrations of chromosome 17 and p53
gene expression and their correlation to histologic grading and
prognosis in primary invasive squamous cell carcinoma of the
cervix. Gynecol Obstet Invest. 51:233–239. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bruening W, Prowse AH, Schultz DC,
Holgado-Madruga M, Wong A and Godwin AK: Expression of OVCA1, a
candidate tumor suppressor, is reduced in tumors and inhibits
growth of ovarian cancer cells. Cancer Res. 59:4973–4983.
1999.PubMed/NCBI
|
|
12
|
Kong FD, Zhao CY, Jia LY, Miao XY, Wei W,
Zhao XY, Yang G and Sun WP: Cloning of human OVCA1 gene and its in
vitro inhibitory effect on ovarian cancer cell growth. Int J Lab
Med. 16:1805–1806. 2011.
|
|
13
|
Zhu BZ: The study on the correlation of
tumor suppressor gene of OVCA1 and cervical cancer (unpublished PhD
thesis). Dalian Medlical University. 2010.
|
|
14
|
Pecorelli S: Revised FIGO staging for
caicinoma of the vulva, cervix, and endometrium. Int J Gynaecol
Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Richart RM: Cervical intraepithelial
neoplasia. Pathol Annu. 8:301–328. 1973.PubMed/NCBI
|
|
16
|
Cervical Intraepithelial Neoplasia (CIN)
Pipeline Review. H2 2015. Research and Markets. 2016.
|
|
17
|
Pierre PL Martin-Hirsch, Evangelos
Paraskevaidis, Andrew Bryant, Heather O Dickinson and Sarah L Keep:
Surgery for cervical intraepithelial neoplasia Pierre PL
Martin-Hirsch1. Cochrane Database Syst Rev CD001318. 2010.
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-timequantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kiaer SK, Frederiksen K, Munk C and Iftner
T: Long-term absolute risk of cervical intraepithelial neoplasia
grade 3 or worse following human papillomavirus infection: Role of
persistence. J Natl Cancer Inst. 102:1478–1488. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rodriguez AC, Schiffman M, Herrero R,
Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillén D, Alfaro M,
Morales J, et al: Longitudinal study of human papillomavirus
persistence and cervical intraepithelial neoplasia grade 2/3:
Critical role of furation of infection. J Natl Cancer Inst.
102:315–324. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tong R, Yang Q and Wang CY: Research
advances on tumor suppressor gene OVCA1. Lett Biotechnology.
2:258–263. 2015.
|
|
22
|
Schultz DC, Vanderveer L, Berman DB,
Hamilton TC, Wong AJ and Godwin AK: Identification of two candidate
tumor uppressor genes on chromosome 17p13.3. Cancer Res.
56:1997–2002. 1996.PubMed/NCBI
|
|
23
|
Voeghtly LM, Mamula K, Campbell JL,
Shriver CD and Ellsworth RE: Molecular alterations associated with
breast cancer mortality. PLoS One. 7:e468142012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang GL, Yang H and Xu K: Loss of
heterozygosity on chromosome 17p13.3 in ovarian cancer and cervical
cancer. Zhonghua Zhong Liu Za Zhi. 19:401–403. 1997.(In Chinese).
PubMed/NCBI
|
|
25
|
Park SY, Kang YS, Kim BG, Lee SH, Lee ED,
Lee KH, Park KB and Lee JH: Loss of heterozygosity on the short arm
of chromosome 17 in uterine cervical carcinomas. Cancer Genet
Cytogenet. 79:74–78. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shikeeva AA, Kekeeva TV, Zavalishina LÉ,
Andreeva IuIu and Frank GA: Allelic imbalance in patients with
non-small cell lung cancer. Arkh Patol. 75:3–8. 2013.(In Russian).
PubMed/NCBI
|
|
27
|
Zhang B, Jia WH, Matsuda K, Kweon SS,
Matsuo K, Xiang YB, Shin A, Jee SH, Kim DH, Cai Q, et al:
Large-scale genetic study in East Asians identifies six new loci
associated with colorectal cancer risk. Nat Genet. 46:533–542.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Smardova J, Liskova K, Ravcukova B,
Kubiczkova L, Sevcikova S, Michalek J, Svitakova M, Vybihal V, Kren
L and Smarda J: High frequency of temperature-sensitive mutants of
p53 in glioblastoma. Pathol Oncol Res. 19:421–428. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kanamori M, Sano A, Yasuda T, Hori T and
Suzuki K: Array-based comparative genomic hybridization for
genomic-wide screening of DNA copy number alterations in aggressive
bone tumors. J Exp Clin Cancer Res. 31:1002012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ninomiya S, Tyybäkinoja A, Borze I, Räty
R, Saarinen-Pihkala UM, Usvasalo A, Elonen E and Knuutila S:
Integrated analysis of gene copy number, copy neutral LOH, and
microRNA profiles in adult acute lymphoblastic leukemia. Cytogenet
Genome Res. 136:246–255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen CM and Behringer RR: Ovcal regulates
cell proliferation, embryonic development, and tumorigenesis. Genes
Dev. 18:320–332. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kong FD, Liu L, Wei W, Zhao XY, Miao XY
and Zhao CY: Tumor suppressor gene OVCAl inhibits migration and
invasion of ovarian cancer cells A2780 in vitro. Chin J Cancer
Biother. 154:351–355. 2008.
|
|
33
|
Zhang JF: The expression of OVCA1 and P53
in ovarian serous Tumors (unpublished PhD thesis). Dalian Medlical
University. 2011.
|
|
34
|
Kong F, Tong R, Jia L, Wei W, Miao X and
Zhao C: OVCA1 inhibits the proliferation of epithelial ovarian
cancer cells by decreasing cyclin D1 and increasing p16. Mol Cell
Biochem. 354:199–205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liang XX, Liang JF, Xiao H, Cheng CX, Zhao
YZ and Zheng HX: Expression and clinicopathological significance of
OVCA1 and HIC1 in ovarian epithelial tumors. Chinese Remedies
Clinics. 113:255–258. 2011.
|
|
36
|
Wiper DW and Zanotti KM: Analysis of
allelic imbalance on chromosome 17p13 in stage I and stage II
epithelial ovarian cancers. Gynecol Oncl. 71:77–82. 1998.
View Article : Google Scholar
|
|
37
|
Phillips NJ, Ziegler MR, Radford DM, Fair
KL, Steinbrueck T, Xynos FP and Donis-Keller H: Allelic deletion on
chromosome 17p13.3 in early ovarian cancer. Cancer Res. 56:606–611.
1996.PubMed/NCBI
|
|
38
|
Wang Q, Deng J and Jiang YX: Research
progress of cyclin D1. J Modern Oncol. 2:350–353. 2009.
|
|
39
|
Liang S, Mu K, Wang Y, Zhou Z, Zhang J,
Sheng Y and Zhang T: CyclinD1 a prominent prognostic marker for
endometrial diseases. Diagnostic Pathology. 8:1382013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lu S, Zhang BH and Wang Z: Expression of
survivin, cyclin D1, p21(WAF1), caspase-3 in cervical cancer and
its relation with prognosis. J Huazhong Univ Sci Technolog Med Sci.
25:78–81. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu XL: Expression of OVCAl gene and its
relation with the Expression of cyclin D1 in epithelial ovarian
tissue (unpublished PhD thesis). Dalian Medlical University.
2007.
|
|
42
|
Kamb A: Cell-cycle regulators and cancer.
Trends Genet. 11:136–140. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kamb A, Gruis NA, Weaver-Feldhaus J, Liu
Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE and
Skolnick MH: A cell cycle regulator potentially involved in genesis
of many tumour types. Science. 264:436–440. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Velez Abreu AM and Howard MS:
Tumor-suppressor Genes, cell cycle regulatory checkpoints and the
skin. N Am J Med Sci. 7:176–188. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hao HB and XU PQ: Research progress of
relationship between tumor suppressor gene p16 and malignant tumor.
J Bengbu Medical College. 3:361–363. 2012.
|
|
46
|
Huang K, Li LA, Meng YG and Fu XY: p16
expression in patients with cervical cancer and its prognostic
significance: Meta-analysis of published literature. Eur J Obstet
Gynecol Reprod Biol. 183:64–69. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cai S and Han K: Research on expression
and importance of p53, p16 and VEGF-C in cervical cancer. J Gynecol
Obstet Biol Reprod (Paris). 44:639–645. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Krishnappa P, Mohamad IB, Lin YJ and Barua
A: Expression of P16 in high-risk human papillomavirus related
lesions of the uterine cervix in a government hospital, Malaysia.
Diagn Pathol. 202:2014.
|
